2017 annual financial data
GT Biopharma 2017 Net margin
Direct answer
Net margin was -533,970.37%.
Operating income was -135,570,000 USD and net income was -144,172,000 USD.
Operating cash flow was -5,430,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,000 USD
- Operating income
- -135,570,000 USD
- Net income
- -144,172,000 USD
- Operating cash flow
- -5,430,000 USD